ÌÇÐÄÆƽâ°æ

Biotechnology in Pharma: Global

Statistics report about pharmaceutical biotechnology worldwide

This report presents key facts and figures about the global industry of biotechnology in the pharma sector. Biotech is becoming more and more influentialwithin the broader (bio)pharmaceutical industry. This report is providing a global overview of this industry, with a focus on technology, innovation, and funding and deals activity.

Download your Report

  We value your privacy and will never rent or sell your email address.

Privacy

Table of contents

Market overview

5
  • Premium Statistic Total worldwide prescription drug revenue - projection 2018-2032
  • Premium Statistic Global biotech drug sales estimate 2012-2024
  • Basic Statistic Percentage of global pharmaceutical sales by technology 2016-2030
  • Premium Statistic Biotech pharmaceuticals projected pipeline value worldwide 2020-2025, by modality
  • Premium Statistic Share of pharmaceuticals projected pipeline value worldwide 2024-2030, by modality

Competitive landscape

4
  • Premium Statistic Major global biotech companies' selection based on market cap 2026
  • Premium Statistic Gross profit margin of select U.S. biotech and drug companies Q1-Q4 2025
  • Premium Statistic Dedicated biotechnology company number comparison by select country 2023
  • Premium Statistic Leading global biotech companies 2024, by number of employees

Products & platforms

5
  • Premium Statistic Leading biotech drugs based on revenue 2025
  • Basic Statistic Leading mRNA biotech companies' market cap 2026
  • Premium Statistic mRNA vaccine and therapy market value worldwide 2020-2030
  • Premium Statistic CRISPR-Cas gene market size projections globally 2023 vs 2033
  • Premium Statistic Global cell and gene therapy manufacturing market forecast 2023-2034

R&D economics

5
  • Premium Statistic Top global biotech companies — R&D expenditure 2024
  • Basic Statistic Leading 50 global pharmaceutical and biotech companies 2024, by R&D intensity
  • Premium Statistic Average R&D cost to develop new biopharma compound 2013-2025
  • Basic Statistic Rate of return on biopharma R&D late-stage pipeline 2013-2025
  • Basic Statistic Biotechs: duration of COVID-19 response compared to previous health threats 2003-2019

Funding & deal activity

7
  • Basic Statistic Total raised capital in U.S. and Europe biotechnology industry 2015-2024
  • Basic Statistic Venture capital in U.S. and Europe biotechnology industry 2015-2024
  • Premium Statistic Gene, cell, and RNA therapy startup financing quarterly Q4 2021-Q4 2025
  • Premium Statistic Value of top U.S. biotech IPOs 2024
  • Basic Statistic Top M&As involving U.S. and European biotech companies 2024
  • Basic Statistic Alliances U.S. and Europe biotech companies by total potential value 2024
  • Premium Statistic Biotechnology funding by National Institutes for Health 2013-2024

Valuation & outlook

5
  • Premium Statistic Nasdaq Biotech index closing values 2000-2025
  • Basic Statistic Enterprise aggregate value in biopharma subsectors worldwide 2026
  • Basic Statistic Enterprise value change in biopharma subsectors worldwide 2025-2026
  • Premium Statistic Major pharma and biotech drug launches in 2026, by revenue estimates for 2032
  • Premium Statistic Pharmaceuticals projected pipeline value CAGR worldwide 2020-2025, by modality
Report this content
FURTHER REPORTS

Recommended and recent reports

Recommended statistics

You may also be interested in...
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch